Table 6.
Seroprevalence detected for anti-SARS-CoV-2 antibodies in German health care workers.
| Period | N | SARS-CoV-2 antibody rate | SARS-CoV-2 infection rate | Assay used | Additional information | |
|---|---|---|---|---|---|---|
| Krankenhaus Reinbek | 9 weeks | 871 | 4.36% | 0.344% | Mikrogen/Euroimmun | Ongoing |
| Behrens et al., 2020a | 6 weeks | 217 | 1.86% | Not performed | Euroimmun | Questionnaire used, ongoing trial |
| Schmidt et al., 2020 | 10 days | 406 | 2.9% | Not performed | Euroimmun | Questionnaire used |
| Korth et al., 2020 | 4 weeks | 317 | 1.6% | Not performed | Euroimmun | |
| Fill Malfertheiner et al., 2020 | 12 weeks | 166 | 12.65% | 16.27% | Euroimmun/Elecsys | |
| Epstude and Harsch, 2020 | 15 days | 65 | 1.54% | Not performed | Euroimmun | |
| Harsch et al., 2020 | 5 days | 18 | 0% | Not performed | Euroimmun | Single ward |